98 related articles for article (PubMed ID: 2467892)
1. Beta-thalassemia intermedia in two Turkish families is caused by the interaction of Hb Knossos [beta 27(B9)Ala----Ser] and of Hb City of Hope [beta 69(E13)Gly----ser] with beta (0)-thalassemia.
Kutlar A; Kutlar F; Aksoy M; Gurgey A; Altay C; Wilson JB; Diaz-Chico JC; Hu H; Huisman TH
Hemoglobin; 1989; 13(1):7-16. PubMed ID: 2467892
[TBL] [Abstract][Full Text] [Related]
2. Precision genome editing offers hope for treatment of β-thalassemia and other genetic disorders.
Abbas Z; Rahman A; Aslam B; Aftab S; Feng C; Baloch Z
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102204. PubMed ID: 38800557
[No Abstract] [Full Text] [Related]
3. A silent hemoglobin variant detected by HPLC: hemoglobin City of Hope beta 69 (E13) Gly----Ser.
Rahbar S; Asmerom Y; Blume KG
Hemoglobin; 1984; 8(4):333-42. PubMed ID: 6434492
[TBL] [Abstract][Full Text] [Related]
4. Co-inheritance of the rare β hemoglobin variants Hb Yaounde, Hb Görwihl and Hb City of Hope with other alterations in globin genes: impact in genetic counseling.
Vinciguerra M; Passarello C; Leto F; Cassarà F; Cannata M; Maggio A; Giambona A
Eur J Haematol; 2015 Apr; 94(4):322-9. PubMed ID: 25113778
[TBL] [Abstract][Full Text] [Related]
5. Coinheritance of Hb City of Hope (
Zhou JY; Jiang F; Li J; Chen GL; Li DZ
Hemoglobin; 2019 Mar; 43(2):145-147. PubMed ID: 31268351
[TBL] [Abstract][Full Text] [Related]
6. Utility of rapid whole-exome sequencing in the diagnosis of Niemann-Pick disease type C presenting with fetal hydrops and acute liver failure.
Rohanizadegan M; Abdo SM; O'Donnell-Luria A; Mihalek I; Chen P; Sanders M; Leeman K; Cho M; Hung C; Bodamer O
Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 28802248
[TBL] [Abstract][Full Text] [Related]
7. Different forms of Hb Le Lamentin. An unexpected finding in Hba1c quantification.
Martínez-López R; de la Fuente-Gonzalo F; Nieto JM; Gallar CB; Román CR; Villegas A; González FA; Martínez R; Casado LN; Ropero P
Clin Biochem; 2016 Jan; 49(1-2):57-60. PubMed ID: 26436569
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results.
Tabor HK; Auer PL; Jamal SM; Chong JX; Yu JH; Gordon AS; Graubert TA; O'Donnell CJ; Rich SS; Nickerson DA; ; Bamshad MJ
Am J Hum Genet; 2014 Aug; 95(2):183-93. PubMed ID: 25087612
[TBL] [Abstract][Full Text] [Related]
9. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.
Bodian DL; McCutcheon JN; Kothiyal P; Huddleston KC; Iyer RK; Vockley JG; Niederhuber JE
PLoS One; 2014; 9(4):e94554. PubMed ID: 24728327
[TBL] [Abstract][Full Text] [Related]
10. Structural study of hemoglobin Knossos, beta 27 (B9) Ala leads to Ser. A new abnormal hemoglobin present as a silent beta-thalassemia.
Arous N; Galacteros F; Fessas P; Loukopoulos D; Blouquit Y; Komis G; Sellaye M; Boussiou M; Rosa J
FEBS Lett; 1982 Oct; 147(2):247-50. PubMed ID: 7173395
[TBL] [Abstract][Full Text] [Related]
11. 'Silent' beta-thalassaemia caused by a 'silent' beta-chain mutant: the pathogenesis of a syndrome of thalassaemia intermedia.
Fessas P; Loukopoulos D; Loutradi-Anagnostou A; Komis G
Br J Haematol; 1982 Aug; 51(4):577-83. PubMed ID: 7104238
[TBL] [Abstract][Full Text] [Related]
12. Abnormal processing of beta Knossos RNA.
Orkin SH; Antonarakis SE; Loukopoulos D
Blood; 1984 Jul; 64(1):311-3. PubMed ID: 6733281
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin Knossos: a clinical, laboratory, and epidemiological study.
Fessas P; Loukopoulos D; Kokkinou S; Papasotiriou Y; Karaklis A
Am J Hematol; 1986 Feb; 21(2):119-33. PubMed ID: 3942130
[TBL] [Abstract][Full Text] [Related]
14. Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer's Disease.
Yang Y; Bagyinszky E; An SSA
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176125
[TBL] [Abstract][Full Text] [Related]
15. Generation of two induced pluripotent stem cell lines (CHOCi002-A and CHOCi003-A) from Pompe disease patients with compound heterozygous mutations in the GAA gene.
Christensen C; Heckman P; Rha A; Kan SH; Harb J; Wang R
Stem Cell Res; 2023 Jun; 69():103117. PubMed ID: 37167752
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive map of human glucokinase variant activity.
Gersing S; Cagiada M; Gebbia M; Gjesing AP; Coté AG; Seesankar G; Li R; Tabet D; Weile J; Stein A; Gloyn AL; Hansen T; Roth FP; Lindorff-Larsen K; Hartmann-Petersen R
Genome Biol; 2023 Apr; 24(1):97. PubMed ID: 37101203
[TBL] [Abstract][Full Text] [Related]
17. Individualized Assessment of Exercise Capacity in Response to Acute and Long-Term Enzyme Replacement Therapy in Pediatric Pompe Disease.
Bar-Yoseph R; Tal G; Dumin E; Hanna M; Mainzer G; Zucker-Toledano M; Shallufi G; Jahshan M; Mandel H; Bentur L
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834457
[TBL] [Abstract][Full Text] [Related]
18. Tunisian Maturity-Onset Diabetes of the Young: A Short Review and a New Molecular and Clinical Investigation.
Moalla M; Safi W; Babiker Mansour M; Hadj Kacem M; Mahfood M; Abid M; Kammoun T; Hachicha M; Mnif-Feki M; Hadj Kacem F; Hadj Kacem H
Front Endocrinol (Lausanne); 2021; 12():684018. PubMed ID: 34393998
[TBL] [Abstract][Full Text] [Related]
19. Recognition of maturity-onset diabetes of the young in China.
Liang H; Zhang Y; Li M; Yan J; Yang D; Luo S; Zheng X; Yang G; Li Z; Xu W; Groop L; Weng J
J Diabetes Investig; 2021 Apr; 12(4):501-509. PubMed ID: 32741144
[TBL] [Abstract][Full Text] [Related]
20. Homozygous Hypomorphic
Misra S; Hassanali N; Bennett AJ; Juszczak A; Caswell R; Colclough K; Valabhji J; Ellard S; Oliver NS; Gloyn AL
Diabetes Care; 2020 Apr; 43(4):909-912. PubMed ID: 32001615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
